Back to Results

Afya Ltd (AFYA)

Featured in Small-Cap Stocks

Afya Ltd is a Brazil-based medical education group listed on the NASDAQ as common stock. Founded in 1999 and headquartered in Belo Horizonte, the company serves physicians, medical students, and other learners through a range of education and healthcare technology activities. Its operations are organized into three segments: Undergraduate, Continuing Education, and Medical Practice Solutions.

The Undergraduate segment provides medical and other health-related degree programs, along with selected non-health undergraduate courses. Continuing Education focuses on residency exam preparation, specialization test preparation, graduate medical courses, and professional development delivered in digital and in-person formats. Medical Practice Solutions includes clinical decision support tools, practice management software, digital healthcare services, electronic medical records, telemedicine, digital prescription capabilities, and related platforms. Afya also supplies printed and digital content, an online medical education platform, and other learning resources for healthcare professionals and students.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-AFYA
$20.60
49.1% Upside
Undervalued
$16.80
21.7% Upside
Undervalued
Great
—
—
0.6565
4.7%
August 26, 2026
8.3x
1.3x
1.7x
1.245 B
1.568 B
33.4%
—
10.0
19.1%
184.1%
Send a message
Valuation • Fair Value

Afya Ltd (NASDAQ-AFYA) Fair Value by Valuation Model

Compare the primary fair value estimate for Afya Ltd (NASDAQ-AFYA) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$20.60

Estimated upside of 49.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$24.07

Discounted cash flow valuation reference.

Ben Graham Formula Value

$18.54

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$20.22

Earnings power value estimate.

Comps Fair Value

$17.18

Comparable-company valuation reference.

Analyst Price Target

$16.80

Analysts imply upside of 21.7%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Afya Ltd (NASDAQ-AFYA) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Afya Ltd (NASDAQ-AFYA)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

728.6 M

Current operating scale indicator.

Revenue Forecast

790.3 M

Forward revenue estimate.

EBITDA

286.6 M

Current operating profitability reference.

EBITDA Forecast

341 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Afya Ltd (NASDAQ-AFYA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Afya Ltd (NASDAQ-AFYA)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

9

Relatively strong quality score.

Beneish M-Score

-2.66

No elevated caution signal from this screen.

Altman Z-Score

10.0

Relatively strong balance-sheet zone.

FCF / Net Income

184.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Afya Ltd (NASDAQ-AFYA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Afya Ltd (NASDAQ-AFYA)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 26, 2026

Days to Earnings

36

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

4.7%

Income yield reference.

Upcoming Dividend

0.6565

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

19.1%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Afya Ltd (NASDAQ-AFYA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Afya Ltd (NASDAQ-AFYA) Stock Forecast & Technical Outlook

Review Afya Ltd (NASDAQ-AFYA) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Afya Ltd (NASDAQ-AFYA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Afya Ltd (NASDAQ-AFYA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Afya Ltd (NASDAQ-AFYA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Afya Ltd (NASDAQ-AFYA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Afya Ltd (NASDAQ-AFYA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Afya Ltd (NASDAQ-AFYA)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Afya Ltd (NASDAQ-AFYA) has a Hold consensus, with 0 buy, 5 hold and 3 sell recommendations in the current data set.

Buy 0
Hold 5
Sell 3
FAQ • Fast Investor Answers

Afya Ltd (NASDAQ-AFYA) Stock FAQ

Quick answers about Afya Ltd (NASDAQ-AFYA) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$20.60
Estimated upside 49.1%
Valuation Rating
Undervalued
Estimated upside of 49.1%
Analyst Target
$16.80
Implied upside 21.7%
Financial Health
Great
Current financial-health read

The current fair value estimate for Afya Ltd (NASDAQ-AFYA) is $20.60. This implies an estimated upside of 49.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 49.1% versus the current market price.

The available analyst price target for Afya Ltd (NASDAQ-AFYA) is $16.80. The analyst target implies estimated upside of 21.7%.

The current financial health read for Afya Ltd (NASDAQ-AFYA) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Afya Ltd (NASDAQ-AFYA) is August 26, 2026.

Based on the current data, dividend yield is 4.7%, upcoming dividend amount is 0.6565.

The current P/E ratio listed for Afya Ltd (NASDAQ-AFYA) is 8.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Afya Ltd is 1.245 B.

The current enterprise value listed for Afya Ltd is 1.568 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Afya Ltd is NASDAQ-AFYA, and the stock is listed on NASDAQ.

Afya Ltd (NASDAQ-AFYA) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Afya Ltd is 33.4%, which helps investors evaluate the company’s financing structure and leverage profile.

Similar Diversified Consumer Services Stocks on NASDAQ View more

Liberty Live Group Series A (LLYVA) Liberty Live Group Series A (LLYVA)
Liberty Live Group Series C (LLYVK) Liberty Live Group Series C (LLYVK)
Duolingo Inc (DUOL) Duolingo Inc (DUOL)
Frontdoor Inc (FTDR) Frontdoor Inc (FTDR)
Laureate Education Inc (LAUR) Laureate Education Inc (LAUR)
Grand Canyon Education Inc (LOPE) Grand Canyon Education Inc (LOPE)
OneSpaWorld Holdings Ltd (OSW) OneSpaWorld Holdings Ltd (OSW)
Driven Brands Holdings Inc (DRVN) Driven Brands Holdings Inc (DRVN)
Perdoceo Education Corp (PRDO) Perdoceo Education Corp (PRDO)
Strategic Education Inc (STRA) Strategic Education Inc (STRA)
Lincoln Educational Services (LINC) Lincoln Educational Services (LINC)
American Public Education Inc (APEI) American Public Education Inc (APEI)
Matthews International Corporation (MATW) Matthews International Corporation (MATW)
Charming Medical Ltd (MCTA) Charming Medical Ltd (MCTA)
Super X AI Technology Ltd (SUPX) Super X AI Technology Ltd (SUPX)
JIA DA CORP (JDZG) JIA DA CORP (JDZG)
WW International Inc (WW) WW International Inc (WW)
SunCar Technology Group Inc (SDA) SunCar Technology Group Inc (SDA)
Beachbody Company Inc (BODI) Beachbody Company Inc (BODI)
Regis Corporation (RGS) Regis Corporation (RGS)
Leifras Co Ltd ADR (LFS) Leifras Co Ltd ADR (LFS)
ATA Inc (AACG) ATA Inc (AACG)
Ruanyun Edai Tech Inc (RYET) Ruanyun Edai Tech Inc (RYET)
YSX Tech Co Ltd (YSXT) YSX Tech Co Ltd (YSXT)